These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23702358)

  • 1. Genotype-driven recruitment: a strategy whose time has come?
    Budin-Ljøsne I; Soye KJ; Tassé AM; Knoppers BM; Harris JR
    BMC Med Genomics; 2013 May; 6():19. PubMed ID: 23702358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical, legal and social/societal implications (ELSI) of recall-by-genotype (RbG) and genotype-driven-research (GDR) approaches: a scoping review.
    Tschigg K; Consoli L; Biasiotto R; Mascalzoni D
    Eur J Hum Genet; 2022 Sep; 30(9):1000-1010. PubMed ID: 35705790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for ethical approaches to genotype-driven research recruitment.
    Beskow LM; Fullerton SM; Namey EE; Nelson DK; Davis AM; Wilfond BS
    Hum Genet; 2012 Sep; 131(9):1423-31. PubMed ID: 22622788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.
    Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA
    Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closure of population biobanks and direct-to-consumer genetic testing companies.
    Zawati MH; Borry P; Howard HC
    Hum Genet; 2011 Sep; 130(3):425-32. PubMed ID: 21706343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
    Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
    Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing discussion of ethics in mixed methods health services research.
    Stadnick NA; Poth CN; Guetterman TC; Gallo JJ
    BMC Health Serv Res; 2021 Jun; 21(1):577. PubMed ID: 34126980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research.
    Watson RW; Kay EW; Smith D
    Nat Rev Cancer; 2010 Sep; 10(9):646-51. PubMed ID: 20703251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commercial biobanks and genetic research: ethical and legal issues.
    Anderlik M
    Am J Pharmacogenomics; 2003; 3(3):203-15. PubMed ID: 12814328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Governance and measures for the ethical and social aspects of biobanks].
    Iwae S; Masui T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):493-7. PubMed ID: 22504670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 23andMe: a new two-sided data-banking market model.
    Stoeklé HC; Mamzer-Bruneel MF; Vogt G; Hervé C
    BMC Med Ethics; 2016 Mar; 17():19. PubMed ID: 27059184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical governance in biobanks linked to electronic health records.
    Caenazzo L; Tozzo P; Borovecki A
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4182-6. PubMed ID: 26592845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current Condition and Issues of Clinical Biobanks in Japan -From the Point of View of Laboratory Medicine-].
    Matsushita K
    Rinsho Byori; 2017 Feb; 65(2):181-189. PubMed ID: 30762985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ethical and legal aspects of biological sample banks: synthesis, practical questions and proposals].
    Cambon-Thomsen A; Rial-Sebbag E; Duchier J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):121-6. PubMed ID: 12684568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Broad" consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose.
    Petrini C
    Soc Sci Med; 2010 Jan; 70(2):217-20. PubMed ID: 19853341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological and conceptual issues regarding occupational psychosocial coronary heart disease epidemiology.
    Burr H; Formazin M; Pohrt A
    Scand J Work Environ Health; 2016 May; 42(3):251-5. PubMed ID: 26960179
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.